ArticleEpilepsia2026
Dynamic limbic-executive decoupling underpins the reciprocal link between drug-resistant state and depression in temporal lobe epilepsy.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveDepression is the most common psychiatric comorbidity in temporal lobe epilepsy. It is not merely a psychological reaction to seizures; accumulating evidence supports a bidirectional relationship in which mood dysregulation may also precede drug resistance. Here, we tested whether dynamic limbic-executive integration provides an in vivo circuit-level substrate for this reciprocity.
methodsWe cross-sectionally studied 82 patients with temporal lobe epilepsy (33 drug-resistant, 49 drug-responsive) and 50 healthy controls. The drug-resistant state was defined according to International League Against Epilepsy (ILAE) criteria (failure of two appropriate and tolerated anti-seizure medication regimens), and depression severity was indexed by Self-Rating Depression Scale scores. Using resting-state functional magnetic resonance imaging (rs-fMRI), we quantified time-varying large-scale network coupling to characterize limbic interactions with the broader connectome. We then identified specific patterns of limbic disintegration and tested their clinical relevance with mediation models, asking whether limbic integration with executive systems statistically linked drug-resistant state and depression severity bidirectionally. Finally, we spatially correlated network effects with normative positron emission tomography (PET)-derived neurotransmitter receptor/transporter maps and Allen Human Brain Atlas gene-expression profiles, followed by pathway enrichment analyses.
resultsThe drug-resistant state was characterized by dynamic decoupling of the limbic network from dorsal attention and frontoparietal systems. Reduced limbic-dorsal attention integration tracked depression severity and statistically mediated both the pathway from the drug-resistant state to depression (indirect = 2.18, 95% confidence interval [CI] = 0.20-4.54) and the reverse pathway from depression to the drug-resistant state (indirect = 0.022, 95% CI = 0.006-0.049). The spatial signature of limbic-executive disintegration co-localized with higher serotonin (5-HT) 1B receptor (5-HT1B) and lower dopamine D2 receptor distributions and was transcriptomically enriched for cellular stress adaptation and cell-fate pathways, including translation reinitiation, telomerase activity, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptotic signaling. SIGNIFICANCE: These convergent multi-scale results propose a dynamic limbic-executive disintegration model of the reciprocity between seizure intractability and depression. Our findings reframe comorbidity as coupled systems-level dysfunction and motivate integrated stratification and target prioritization for dual-burden-focused neuromodulatory intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.